Global Smart Syringes Market

Smart Syringes Market Size, Share, Growth Analysis, By Product(Auto-disable syringes, Active safety syringes, Passive safety syringes), By Application(Drug delivery, Vaccination, Blood specimen collection), By Age Group(Pediatrics and Adults), By End User(Hospitals and HMOs, Diabetic Patients, Family Practices, Psychiatrics), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2214 | Region: Global | Published Date: July, 2024
Pages: 242 | Tables: 117 | Figures: 77

Smart Syringes Market Dynamics

Smart Syringes Market Driver

  • Increasing incidence of various target diseases

As the prevalence of targeted diseases has increased, vaccination programs against targeted diseases have increased in various regions of the world. Also, the need to reduce hospital-acquired infections will drive the demand for smart syringes during the projection period. Smart syringes are in high demand due to the growing elderly population worldwide.

  • Increasing demand for safety syringes in emerging economies

Asia-Pacific and Latin American market growth are attractive for smart syringes. Due to the increase in needle stick injuries and the spread of HIV and hepatitis, the use of traditional syringes has stopped. Also, the adoption of smart syringes is rapidly increasing due to the growing desire for safer injection procedures.

  • Increase in the prevalence of chronic disease

The increase in needle stick injuries has significantly impacted the smart syringe market. Because needle stick injuries are the leading cause of blood-borne infections among healthcare workers, the impact of this factor is expected to increase during the forecast period. These injuries can spread human immunodeficiency virus (HIV), hepatitis B, and hepatitis C. Other diseases can be blast mycosis, brucellosis, cryptococcosis, diphtheria, cutaneous gonorrhoea, herpes, malaria, mycobacteriosis, sporotrichosis, syphilis, and tuberculosis, are transmitted through needle stick injuries.

Smart Syringes Market Restraint

  • High-cost and unaffordable safety syringes

Smart syringes are more expensive than standard syringes, making their worldwide implementation challenging. Some versions cost the same as single-use syringes. Others can cost up to five times more than others, depending on the technological advancement of the security systems, making them unaffordable in some low-and middle-income countries. Also, the high capital expenditure required to develop and maintain some safety syringes, as well as price fluctuations due to technologically improved syringes, hamper the market growth. 

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Smart Syringes Market size was valued at USD 8.45 billion in 2022 and is poised to grow from USD 9.11 billion in 2023 to USD 16.61 billion by 2031, growing at a CAGR of 7.80% in the forecast period (2024-2031).

Global smart syringes market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global smart syringes market. For example, on 29 December 2020, Hindustan Syringes and Medical Devices (HMD), a medical disposables manufacturer, announced that it has increased production of Kojak auto-disable (AD) syringes, to meet the demand for the COVID vaccine. The company plans to increase production from 700 million Kojak Auto Disable (AD) syringes annually to one billion by June 2021. 'Becton, Dickinson and Company', 'Gerresheimer AG', 'Cardinal Health, Inc.', 'Terumo Corporation', 'Retractable Technologies, Inc.', 'Unilife Corporation', 'AdvaCare Pharma', 'Parker Hannifin Corporation', 'Sol-Millennium Medical Group Co. Ltd.', 'Smiths Group plc', 'GPC Medical Ltd.', 'Sterimed Group', 'Nipro Corporation', 'Braun Melsungen AG', 'UltiMed, Inc.', 'West Pharmaceutical Services, Inc.', 'Gerresheimer AG', 'OMNICELL, Inc.', 'QIAGEN N.V.', 'Integran Technologies, Inc.'

Increasing incidence of various target diseases

Smart syringes are generally used in vaccination, drug administration, and blood sampling, among which drug administration is the most common application area of ​​these syringes. Demand for Auto-disabled (AD) syringes from hospitals and HMOs has been at its highest for the past few years. These syringes find maximum use in the routine administration of drugs and fluids, due to which the demand for them is likely to remain high for the next few years. The use of the passive safety syringe segment is a key trend and is also expected to gain significant momentum in the coming years.

On the basis of region, global smart syringes market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America leads the global smart syringe market and accounts for more than 40% of the market revenue owing to growing need for modern healthcare technology. Also, greater awareness of blood-borne infections as a result of unsafe injection practices has increased the demand for smart syringes in North America. Also, the rising incidence of chronic diseases and the presence of a large number of elderly individuals in the region, along with rising healthcare costs, are driving the demand for smart syringes across North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Smart Syringes Market

Report ID: SQMIG35A2214

$5,300
BUY NOW GET FREE SAMPLE